ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

REPL Replimune Group Inc

6,95
0,39 (5,95%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Replimune Group Inc REPL NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,39 5,95% 6,95 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,80 6,605 7,08 6,95 6,56
mais cotações »

Notícias Recentes

Data Hora Fonte Título
07/04/202418:00GLOBEInterim Results from the ARTACUS Clinical Trial of RP1..
04/04/202409:00GLOBEReplimune Announces Inducement Grants Under Nasdaq Listing..
26/03/202408:30GLOBEReplimune Announces Appointment of Sushil Patel to CEO and..
06/03/202410:00GLOBEReplimune to Present at the American Association for Cancer..
05/03/202410:00GLOBEReplimune to Present at Three Upcoming Investor Conferences
08/02/202410:00GLOBEReplimune Reports Fiscal Third Quarter 2024 Financial..
16/01/202406:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/01/202405:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
28/12/202310:00GLOBEReplimune to Present at the 42nd Annual J.P. Morgan..
05/12/202309:00GLOBEReplimune Shares Initial Primary Analysis Results from..
08/11/202311:10GLOBEReplimune Presents Updated Data on RP2 in Uveal Melanoma..
07/11/202310:00GLOBEReplimune Reports Fiscal Second Quarter 2024 Financial..
03/11/202320:30GLOBEReplimune Presents Updated Interim Results from the ARTACUS..
19/09/202317:01GLOBEReplimune Announces Inducement Grants Under Nasdaq Listing..
19/09/202309:00GLOBEReplimune Announces Appointment of Emily Hill as Chief..
03/08/202309:00GLOBEReplimune Reports Fiscal First Quarter 2024 Financial..
01/08/202309:00GLOBEReplimune to Present at Two Upcoming Investor Conferences
31/07/202317:01BWReplimune and Incyte Enter into Clinical Trial Collaboration..
20/07/202309:00GLOBEReplimune Announces Sander Slootweg will Depart from its..
06/06/202311:00GLOBEReplimune Presents Initial RP1 Data from the ARTACUS..
05/06/202309:00GLOBEReplimune Appoints Veleka R. Peeples-Dyer to its Board of..
03/06/202315:15GLOBEReplimune Presents RP1 Data from the IGNYTE anti-PD1 Failed..
01/06/202317:01GLOBEReplimune to Present at the Jefferies Global Healthcare..
25/05/202318:00GLOBEReplimune to Present at the 2023 American Society of..
18/05/202309:00GLOBEReplimune Reports Fiscal Fourth Quarter and Year Ended 2023..
09/05/202309:00GLOBEReplimune to Participate in the Piper Sandler Spring..

Seu Histórico Recente

Delayed Upgrade Clock